Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATNX
3026
DELISTED
Athenex, Inc. Common Stock
ATNX
| $4.1M | ﹤0.01% |
68,181
-204
| -0.3% | -$14.8K |
|
|
TCS
3027
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $4.1M | ﹤0.01% |
28,718
+1,177
| +4% | +$197K |
|
3028
Sight Sciences
SGHT
$456M
| $4.09M | ﹤0.01% |
+180,226
| New | +$5.92M |
|
|
DOO
3029
Bombardier Recreational Products
DOO
$4.69B
| $4.06M | ﹤0.01% |
43,834
-6,370
| -13% | -$551K |
|
|
EIGR
3030
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $4.06M | ﹤0.01% |
20,260
+312
| +2% | +$74.2K |
|
3031
RELX
RELX
$60.4B
| $4.06M | ﹤0.01% |
139,994
+5,320
| +4% | +$157K |
|
3032
Smith Micro Software
SMSI
$17M
| $4.05M | ﹤0.01% |
20,905
+390
| +2% | +$78.8K |
|
|
BRT
3033
BRT Apartments
BRT
$268M
| $4.04M | ﹤0.01% |
209,807
+4,574
| +2% | +$84.7K |
|
3034
EverQuote
EVER
$867M
| $4.04M | ﹤0.01% |
217,033
-35,959
| -14% | -$860K |
|
|
CBAY
3035
DELISTED
Cymabay Therapeutics
CBAY
| $4.04M | ﹤0.01% |
1,107,091
-38,514
| -3% | -$152K |
|
3036
VirnetX Holding Corp
VHC
$65.8M
| $4.03M | ﹤0.01% |
51,457
+712
| +1% | +$58.2K |
|
3037
Edgewise Therapeutics
EWTX
$4.73B
| $4.03M | ﹤0.01% |
242,919
+497
| +0.2% | +$8.99K |
|
|
CASA
3038
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $4.03M | ﹤0.01% |
593,810
-18,659
| -3% | -$138K |
|
|
ICAD
3039
DELISTED
iCAD Inc
ICAD
| $4.03M | ﹤0.01% |
374,434
-2,773
| -0.7% | -$36.1K |
|
3040
Limoneira
LMNR
$251M
| $4.03M | ﹤0.01% |
248,975
+1,504
| +0.6% | +$25.3K |
|
|
ESTE
3041
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $4.01M | ﹤0.01% |
435,764
+48,225
| +12% | +$443K |
|
3042
Eterna Therapeutics
ERNA
$5.16M
| $4M | ﹤0.01% |
57
+9
| +19% | +$777K |
|
3043
Vera Bradley
VRA
$96.7M
| $3.99M | ﹤0.01% |
424,313
+9,995
| +2% | +$110K |
|
|
ZY
3044
DELISTED
Zymergen Inc. Common Stock
ZY
| $3.99M | ﹤0.01% |
303,017
-51,286
| -14% | -$1.09M |
|
|
ZYXI
3045
DELISTED
Zynex
ZYXI
| $3.98M | ﹤0.01% |
384,174
+2,508
| +0.7% | +$32.2K |
|
3046
XBiotech
XBIT
$75M
| $3.96M | ﹤0.01% |
306,118
+8,196
| +3% | +$131K |
|
|
SNPO
3047
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
| $3.96M | ﹤0.01% |
+237,800
| New | +$4.43M |
|
3048
Newegg Commerce
NEGG
$415M
| $3.96M | ﹤0.01% |
13,884
+10,484
| +308% | +$4.48M |
|
3049
South Plains Financial
SPFI
$858M
| $3.96M | ﹤0.01% |
162,518
+3,029
| +2% | +$70.4K |
|
3050
BeyondSpring
BYSI
$41M
| $3.94M | ﹤0.01% |
250,016
+51,922
| +26% | +$933K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.